Royal Sense Limited Secures Central Procurement Agency Tender, Eyes Sales Uplift of Up to ₹100 Crore Over 2 Years

Mumbai, 16 December 2025: Royal Sense Limited informed the stock exchanges that its proposed merger entity, TTG Innovations Private Limited, has received a significant domestic tender from the Central Procurement Agency under the Directorate General of Health Services (DGHS), Health & Family Welfare, Government of NCT of Delhi. 

The development was disclosed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlighting a potential revenue boost of up to ₹100 crore over the execution period.

Central Procurement Tender Opens Up To ₹100 Crore Public Healthcare Sales Opportunity

The awarded tender covers the supply of various surgical sutures, including absorbable, non-absorbable, monofilament, braided and speciality sutures, strictly aligned with prescribed specifications and quality standards.

According to the company, sales from this contract are expected to rise by up to ₹100 crore, subject to demand-led procurement during the contract tenure. The order has been awarded by a domestic government entity, reinforcing Royal Sense’s footprint in institutional healthcare supplies.

Two-Year Execution Timeline Anchors Long-Term Demand Visibility for Surgical Sutures

The contract is set to be executed over a period of two years, with supplies made on a requirement basis. This structure links revenue recognition directly to ongoing public healthcare demand rather than a one-time shipment. The nature of the order ensures sustained engagement across multiple medical and surgical procedures, positioning the company within essential healthcare procurement channels.

No Related Party Exposure as Tender Awarded by Government Healthcare Authority

Royal Sense Limited clarified that neither the promoter nor the promoter group has any interest in the entity awarding the contract. Additionally, the order does not fall under related party transactions and has been received at arm’s length, addressing governance and disclosure considerations relevant to listed entities.

Merger-Linked Entity TTG Innovations Receives Order After BSE NOC Dated 19 November 2025

The tender has been awarded to TTG Innovations Private Limited, the proposed transferor company slated to merge with Royal Sense Limited. The scheme of arrangement had earlier received a No Objection Certificate from BSE Limited on 19 November 2025, enabling operational developments to be disclosed under the listed entity’s compliance framework. The timing links regulatory clearance with tangible order inflows.

Share Price Jump 5.53% After Order Disclosure

On the BSE, by 1:09 PM IST on 16 December 2025, Royal Sense Ltd share price rose 5.53% to ₹226.90. The stock opened at ₹218.00. The company’s market capitalisation stood at ₹121.39 crore, with a P/E ratio of 15.76, while the stock remains below its 52-week high of ₹316.05.

The tender award underscores Royal Sense Limited’s expanding engagement with government healthcare procurement, backed by a two-year execution window and demand-driven supplies. With no related party exposure and a clear regulatory disclosure trail, the development highlights operational scale-up through public sector orders while maintaining compliance and governance transparency.

Source: https://www.bseindia.com/xml-data/corpfiling/AttachLive/b7a29717-d18b-4184-b17b-5c4f26e18a10.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur. 

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com. 

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations